Evidence map›Paper›PMID 36795492›Full record

ArticleThe Journal of clinical investigation2023

Impaired protein hydroxylase activity causes replication stress and developmental abnormalities in humans.

Sally C Fletcher, Charlotte Hall, Tristan J Kennedy, Sander Pajusalu, Monica H Wojcik, Uncaar Boora, Chan Li, Kaisa Teele Oja, Eline Hendrix, Christian Ae Westrip and 15 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Versatile JMJD proteins: juggling histones and much more.Trends in biochemical sciences · 2024
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 5 institutions in 4 countries.

Sally C FletcherInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
Charlotte HallInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
Tristan J KennedyInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
Sander PajusaluDepartment of Clinical Genetics, Genetics and Personalized Medicine Clinic, Tartu University Hospital, Tartu, Estonia.
Monica H WojcikCenter for Mendelian Genomics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Uncaar BooraInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
Chan LiInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
Kaisa Teele OjaDepartment of Clinical Genetics, Genetics and Personalized Medicine Clinic, Tartu University Hospital, Tartu, Estonia.
Eline HendrixInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
Christian Ae WestripInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
Regina AndrijesInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
Sonia K PiaseckaInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
Mansi SinghInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
Mohammed E El-AsragInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
Anetta PtasinskaInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
Vallo TillmannInstitute of Clinical Medicine, University of Tartu, Tartu, Estonia.
Martin R HiggsInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
Deanna A CarereGeneDx, Gaithersburg, Maryland, USA.
Andrew D BeggsInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
John PappasClinical Genetic Services, Department of Pediatrics, NYU Langone Medical Center, New York, New York, USA.
Rachel RabinClinical Genetic Services, Department of Pediatrics, NYU Langone Medical Center, New York, New York, USA.
Stephen J SmerdonInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
Grant S StewartInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
Katrin ÕunapDepartment of Clinical Genetics, Genetics and Personalized Medicine Clinic, Tartu University Hospital, Tartu, Estonia.
Mathew L ColemanInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
University of Birmingham · GBTartu University Hospital · EENYU Langone Health · USBenha University · EGBroad Institute · US

Funding

Joint Center for Mendelian GenomicsUM1HG008900 · NHGRI · BROAD INSTITUTE, INC. · PI O'DONNELL-LURIA, ANNE, REHM, HEIDI L · 2016 to 2020
$16.5M
A powerful web-based discovery platform for rare disease geneticsR01HG009141 · NHGRI · BROAD INSTITUTE, INC. · PI QUINLAN, AARON R, REHM, HEIDI L · 2017 to 2020
$2.9M
Cancer Research UK 24552Cancer Research UK C17183/A23303Cancer Research UK C33483/A25674Medical Research CouncilNHGRI NIH HHS R01 HG009141NHGRI NIH HHS UM1 HG008900Wellcome Trust FC001003
6 · The paper itself

Abstract

Although protein hydroxylation is a relatively poorly characterized posttranslational modification, it has received significant recent attention following seminal work uncovering its role in oxygen sensing and hypoxia biology. Although the fundamental importance of protein hydroxylases in biology is becoming clear, the biochemical targets and cellular functions often remain enigmatic. JMJD5 is a "JmjC-only" protein hydroxylase that is essential for murine embryonic development and viability. However, no germline variants in JmjC-only hydroxylases, including JMJD5, have yet been described that are associated with any human pathology. Here we demonstrate that biallelic germline JMJD5 pathogenic variants are deleterious to JMJD5 mRNA splicing, protein stability, and hydroxylase activity, resulting in a human developmental disorder characterized by severe failure to thrive, intellectual disability, and facial dysmorphism. We show that the underlying cellular phenotype is associated with increased DNA replication stress and that this is critically dependent on the protein hydroxylase activity of JMJD5. This work contributes to our growing understanding of the role and importance of protein hydroxylases in human development and disease.

Indexed as

Histone DemethylasesMixed Function OxygenasesAnimalsHumansMiceProtein Processing, Post-TranslationalHistone DemethylasesMixed Function OxygenasesCell BiologyDNA repairGenetic diseasesGenetic instabilityGenetics

Identifiers

PMID36795492
PMCPMC10065073
OpenAlexW4321004743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.